10x Genomics, Inc.
TXG
$20.92
$0.422.05%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 85.57% | 76.16% | 58.19% | 64.72% | 40.58% |
| Total Depreciation and Amortization | 9.25% | -3.85% | -9.73% | -14.35% | -13.47% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -24.07% | -21.96% | -24.05% | -22.77% | -20.86% |
| Change in Net Operating Assets | -94.57% | 1,888.76% | -74.69% | -160.30% | 110.70% |
| Cash from Operations | 125.27% | 1,941.57% | 126.00% | 961.12% | 311.74% |
| Capital Expenditure | 50.43% | 52.11% | 47.63% | 58.83% | 75.77% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 106.07% | 108.72% | -205.64% | -173.74% | -147.50% |
| Cash from Investing | 71.53% | 58.82% | -297.21% | -243.04% | -286.84% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -31.39% | -37.67% | -24.41% | -46.90% | -48.20% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -120.99% | -37.67% | -24.41% | -46.90% | -48.20% |
| Foreign Exchange rate Adjustments | 14,950.00% | 395.12% | -5.49% | 711.86% | 98.10% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 432.07% | 953.64% | -58.58% | -63.47% | 33.11% |